{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:43:15Z","timestamp":1759624995663,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neulet.2019.04.037","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:13:14Z","timestamp":1555614794000},"page":"46-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Rewarding effects of 2-desoxypipradrol in mice"],"prefix":"10.1016","volume":"705","author":[{"given":"Hye Jin","family":"Cha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Mook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hsoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Kyung","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"World Drug Report 2017","author":"United Nation Office on Drugs and Crimes","key":"10.1016\/j.neulet.2019.04.037_bib0005"},{"key":"10.1016\/j.neulet.2019.04.037_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/15563650.2012.716158","article-title":"Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)","volume":"50","author":"Wood","year":"2012","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neulet.2019.04.037_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pnpbp.2012.05.021","article-title":"2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): a preliminary review","volume":"39","author":"Corkery","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"year":"2011","series-title":"Consideration of Desoxypipradrol (2-DPMP) and Related Pipradrol Compounds","author":"Advisory Council on the Misuse of Drugs","key":"10.1016\/j.neulet.2019.04.037_bib0020"},{"issue":"3","key":"10.1016\/j.neulet.2019.04.037_bib0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-3565(25)31771-4","article-title":"Comparison of the effects of the isomers of amphetamine, methylphenidate and desoxypipradro on the uptake of I-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus","volume":"210","author":"Ferris","year":"1979","journal-title":"J. Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2019.04.037_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","article-title":"Neurochemical profiles of some novel psychoactive substances","volume":"700","author":"Iversen","year":"2013","journal-title":"Eur. J. Pharmcol."},{"year":"2011","series-title":"Inchem. Methylphenidate hydrochloride. International Programme on Chemical Safety","key":"10.1016\/j.neulet.2019.04.037_bib0035"},{"key":"10.1016\/j.neulet.2019.04.037_bib0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/15563650.2011.647992","article-title":"\u2018Ivory wave\u2019 toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning","volume":"50","author":"Murray","year":"2012","journal-title":"Clin. Toxicol."},{"year":"2018","series-title":"PsychonautWiki-Desoxypipradrol","key":"10.1016\/j.neulet.2019.04.037_bib0045"},{"year":"2007","series-title":"Bluelight, Desoxypipradrol","key":"10.1016\/j.neulet.2019.04.037_bib0050"},{"year":"2007","series-title":"Drugs Forum. 2-DPMP\/Desoxypipradrol","key":"10.1016\/j.neulet.2019.04.037_bib0055"},{"key":"10.1016\/j.neulet.2019.04.037_bib0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","article-title":"Agents in development for management of cocaine abuse","volume":"64","author":"Gorelick","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.neulet.2019.04.037_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(82)91123-4","article-title":"Drug reinforcement studies by the use of place conditioning in rat","volume":"243","author":"Mucha","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.04.037_bib0070","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archneur.64.11.1575","article-title":"Dopamine in drug abuse and addiction: results of imaging studies and treatment implications","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2019.04.037_bib0075","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1471-4159.1982.tb05360.x","article-title":"Tyrosine hydroxylase activity in rat brain synaptosomes: direct measurement using high-performance liquid chromatography","volume":"38","author":"Messripour","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.04.037_bib0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0197-0186(85)90036-1","article-title":"The control of dopamine and serotonin synthesis in rat brain synaptosomes","volume":"7","author":"Messripour","year":"1985","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2019.04.037_bib0085","series-title":"Electrochemical Methods for Neuroscience","first-page":"103","article-title":"Determining serotonin and dopamine uptake rates in synaptosomes using high-speed chronoamperometry","author":"Perez","year":"2007"},{"issue":"1","key":"10.1016\/j.neulet.2019.04.037_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634146","article-title":"Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum","volume":"50","author":"Protair","year":"1976","journal-title":"Psychopharmcology"},{"key":"10.1016\/j.neulet.2019.04.037_bib0095","first-page":"287","article-title":"Effects of catecholamines on dopamine andserotonin synthesis in rat brain striatal synaptosomes: the role of presynaptic receptors and the synaptosomal reuptake mechanism","volume":"2","author":"Messripour","year":"1989","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"10.1016\/j.neulet.2019.04.037_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.32604\/biocell.2013.37.017","article-title":"Age related interaction of dopamine and serotonin synthesis in striatal synaptosomes","volume":"37","author":"Messripour","year":"2013","journal-title":"Biocell"},{"key":"10.1016\/j.neulet.2019.04.037_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-0270(85)90071-8","article-title":"Measurement of noradrenaline synthesis in rat hippocampal synaptosomes using HPLC with ECD","volume":"13","author":"Birch","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neulet.2019.04.037_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2014.01.015","article-title":"Designer psychostimulants: pharmacology and differences","volume":"87","author":"Iversen","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2019.04.037_bib0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.toxlet.2012.04.019","article-title":"Research chemicals marketed as legal highs: the case of pipradrol derivatives","volume":"212","author":"Coppola","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neulet.2019.04.037_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1192\/pb.bp.111.038315","article-title":"Prevalence study of head shop drug usage in mental health services","volume":"37","author":"Lally","year":"2013","journal-title":"Psychiatrist"},{"issue":"7","key":"10.1016\/j.neulet.2019.04.037_bib0125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/0269881111430733","article-title":"Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbens","volume":"26","author":"Davidson","year":"2012","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neulet.2019.04.037_bib0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2019.04.037_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2015.08.037","article-title":"Dopamine prediction errors in reward learning and addiction: from theory to neural circuitry","volume":"88","author":"Keiflin","year":"2015","journal-title":"Neuron"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019302770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019302770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:26:26Z","timestamp":1759609586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019302770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":27,"alternative-id":["S0304394019302770"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.04.037","relation":{},"ISSN":["0304-3940"],"issn-type":[{"type":"print","value":"0304-3940"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rewarding effects of 2-desoxypipradrol in mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}